Saint Mary Medical and Regional Cancer Center — Langhorne, Pennsylvania

Saint Mary Medical and Regional Cancer Center is a clinical research site located in Langhorne, Pennsylvania, United States 19047.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Saint Mary Medical and Regional Cancer Center has participated in 24 clinical trials with 11 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Radiation Therapy Oncology Group.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Mary Medical and Regional Cancer Center?

Saint Mary Medical and Regional Cancer Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Mary Medical and Regional Cancer Center conducted?

Saint Mary Medical and Regional Cancer Center has 24 clinical trials on record, with 11 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Saint Mary Medical and Regional Cancer Center accredited by Crixeo Health?

Yes — Saint Mary Medical and Regional Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Mary Medical and Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.